Xevant Introduces the GLP-1 Dashboard for Effective Cost Management
Xevant, a prominent healthcare analytics provider, has unveiled its pioneering GLP-1 Dashboard, aimed at assisting Pharmacy Benefit Managers (PBMs), payers, health plans, brokers, and consultants in managing the escalating costs associated with GLP-1 therapies. With the rising price of these therapies under scrutiny, Xevant's initiative brings much-needed data-driven insights to the forefront.
The Challenge of Managing Rising Therapy Costs
GLP-1 therapies, known for their efficacy, have seen a remarkable surge in adoption, leading to significant increases in prescription spending. Recent data indicates that between 2020 and 2024, costs related to GLP-1 therapies skyrocketed by a jaw-dropping 1,119 percent for Xevant's clients, while total drug spending saw a rise of about 90 percent within the same timeframe. The alarming trajectory of GLP-1 expenses has created substantial pressure on PBMs and consultants to uphold quality patient care without spiraling costs. The GLP-1 Dashboard stands as a groundbreaking solution, presenting real-time insights into cost, utilization, and efficacy of these therapies.
Understanding the Rising Costs of GLP-1s
As of June 2024, expenditures on GLP-1 therapies accounted for around 11 percent of total plan costs among Xevant’s clients, up from a mere 2 percent in June 2021. Such a dramatic increase, essentially doubling year-over-year, underscores the urgent need for a robust reporting tool to streamline management practices. Brandon Newman, Xevant's founder and CEO, emphasizes the vital role of this dashboard, stating, “PBMs, health plans, and consultants are confronted with substantial challenges in tackling the surging costs of GLP-1 therapies. Until now, tracking utilization and evaluating cost-effectiveness in real time was nearly impossible. Our GLP-1 Dashboard equips them with the necessary insights to make informed, prompt, and impactful decisions.”
The Features of the GLP-1 Dashboard
The new GLP-1 Dashboard promises to empower PBMs and consultants with detailed data to facilitate informed patient care and strategic cost management. Some core features include:
- Cost Control: Track and manage GLP-1 therapy expenses through monthly expenditure data, helping identify and effectively manage high-cost cases.
- Utilization Insights: Examine patient counts and prescription trends for improved adherence tracking and benefit design optimization.
- Data-Driven Decisions: Access actionable insights related to prescribing behaviors and patient demographics, ensuring healthcare providers can offer effective therapies while remaining cost-efficient.
- Enhanced Client Retention: Boost your value proposition with an intuitive, data-rich platform that enhances client acquisition and retention through valuable transparency and strategic guidance.
Impact on Pharmacy Benefit Management
Brandon Newman noted, “Our analysis across the past four years shows GLP-1 utilization has surged by 681 percent, starkly contrasting the modest 3 percent increase in overall medication utilization. The GLP-1 Dashboard is essential for PBMs striving to manage this explosive trend effectively.” Sahily Paoline, Xevant's Chief Clinical Officer, asserted that this dashboard would transform the landscape of GLP-1 therapy management. It equips PBMs and consultants with the tools to negotiate better pricing, optimize benefit designs, and deliver added value insights to clients, promoting better health outcomes while enhancing cost-efficiency across organizations.
About Xevant
Xevant’s innovative data analytics platform integrates real-time automation throughout the pharmacy benefits landscape, focusing on reducing costs while enhancing overall health outcomes. With a strong commitment to customer success and innovation, Xevant is committed to partnering with businesses to revolutionize their pharmacy benefit and reporting practices, facilitating proactive, efficient management that navigates the complexities of the evolving pharmacy sector.
Frequently Asked Questions
What is the purpose of the GLP-1 Dashboard by Xevant?
The GLP-1 Dashboard is designed to provide PBMs and consultants with vital data and analytics to manage costs and therapy utilization effectively.
How have GLP-1 therapy costs changed in recent years?
Costs related to GLP-1 therapies have increased by over 1,119 percent from 2020 to 2024, significantly outpacing general prescription spending.
What are key features of the GLP-1 Dashboard?
Key features include cost control monitoring, utilization insights, data-driven decision-making, and enhanced client retention strategies.
Who can benefit from the GLP-1 Dashboard?
Pharmacy Benefit Managers, health plans, brokers, and consultants can all benefit from the dashboard through improved management and data insights.
How does Xevant support client health outcomes?
Xevant uses its analytics platform to drive down costs and improve health outcomes, ensuring clients receive the best possible insights for effective therapy management.
